These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11168896)

  • 1. Increased antibacterial activity of 15-residue murine lactoferricin derivatives.
    Strøm MB; Rekdal O; Stensen W; Svendsen JS
    J Pept Res; 2001 Feb; 57(2):127-39. PubMed ID: 11168896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial activity of 15-residue lactoferricin derivatives.
    Strøm MB; Rekdal O; Svendsen JS
    J Pept Res; 2000 Nov; 56(5):265-74. PubMed ID: 11095180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of charge and lipophilicity on the antibacterial activity of undecapeptides derived from bovine lactoferricin.
    Strøm MB; Rekdal O; Svendsen JS
    J Pept Sci; 2002 Jan; 8(1):36-43. PubMed ID: 11831560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of a 2-arylsulphonylated tryptophan: the antibacterial activity of bovine lactoferricin peptides containing Trp(2-Pmc).
    Haug BE; Andersen J; Rekdal O; Svendsen JS
    J Pept Sci; 2002 Jul; 8(7):307-13. PubMed ID: 12148780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial activity of short hydrophobic and basic-rich peptides.
    Chen PW; Shyu CL; Mao FC
    Am J Vet Res; 2003 Sep; 64(9):1088-92. PubMed ID: 13677384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bactericidal kinetics of 3 lactoferricins against Staphylococcus aureus and Escherichia coli.
    Ulvatne H; Vorland LH
    Scand J Infect Dis; 2001; 33(7):507-11. PubMed ID: 11515760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of tryptophan in the antibacterial activity of a 15-residue bovine lactoferricin peptide.
    Haug BE; Svendsen JS
    J Pept Sci; 2001 Apr; 7(4):190-6. PubMed ID: 11354462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Important structural features of 15-residue lactoferricin derivatives and methods for improvement of antimicrobial activity.
    Strøm MB; Haug BE; Rekdal O; Skar ML; Stensen W; Svendsen JS
    Biochem Cell Biol; 2002; 80(1):65-74. PubMed ID: 11908644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bulky aromatic amino acids increase the antibacterial activity of 15-residue bovine lactoferricin derivatives.
    Haug BE; Skar ML; Svendsen JS
    J Pept Sci; 2001 Aug; 7(8):425-32. PubMed ID: 11548058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simple parameterization of non-proteinogenic amino acids for QSAR of antibacterial peptides.
    Lejon T; Svendsen JS; Haug BE
    J Pept Sci; 2002 Jul; 8(7):302-6. PubMed ID: 12148779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic porcine lactoferricin with a 20-residue peptide exhibits antimicrobial activity against Escherichia coli, Staphylococcus aureus, and Candida albicans.
    Chen HL; Yen CC; Lu CY; Yu CH; Chen CM
    J Agric Food Chem; 2006 May; 54(9):3277-82. PubMed ID: 16637685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactoferricin of bovine origin is more active than lactoferricins of human, murine and caprine origin.
    Vorland LH; Ulvatne H; Andersen J; Haukland H; Rekdal O; Svendsen JS; Gutteberg TJ
    Scand J Infect Dis; 1998; 30(5):513-7. PubMed ID: 10066056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-antibiotic effect of the antimicrobial peptide lactoferricin on Escherichia coli and Staphylococcus aureus.
    Haukland HH; Vorland LH
    J Antimicrob Chemother; 2001 Oct; 48(4):569-71. PubMed ID: 11581240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of lactoferricin-derived peptides with LPS and antimicrobial activity.
    Farnaud S; Spiller C; Moriarty LC; Patel A; Gant V; Odell EW; Evans RW
    FEMS Microbiol Lett; 2004 Apr; 233(2):193-9. PubMed ID: 15063486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in antimicrobial activity of lactoferricin-derived peptides explained by structure modelling.
    Farnaud S; Patel A; Odell EW; Evans RW
    FEMS Microbiol Lett; 2004 Sep; 238(1):221-6. PubMed ID: 15336425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homology similarity analysis of sequences of lactoferricin and its derivatives.
    Nakai S; Chan JC; Li-Chan EC; Dou J; Ogawa M
    J Agric Food Chem; 2003 Feb; 51(5):1215-23. PubMed ID: 12590458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial activity of peptides homologous to a loop region in human lactoferrin.
    Odell EW; Sarra R; Foxworthy M; Chapple DS; Evans RW
    FEBS Lett; 1996 Mar; 382(1-2):175-8. PubMed ID: 8612745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial activity in bovine lactoferrin-derived peptides.
    Hoek KS; Milne JM; Grieve PA; Dionysius DA; Smith R
    Antimicrob Agents Chemother; 1997 Jan; 41(1):54-9. PubMed ID: 8980754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stochastic-based descriptors studying biopolymers biological properties: extended MARCH-INSIDE methodology describing antibacterial activity of lactoferricin derivatives.
    de Armas RR; Díaz HG; Molina R; Uriarte E
    Biopolymers; 2005 Apr; 77(5):247-56. PubMed ID: 15682438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic activity of pentadecapeptides modelled from amino acid descriptors.
    Lejon T; Strøm MB; Svendsen JS
    J Pept Sci; 2001 Feb; 7(2):74-81. PubMed ID: 11277499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.